Clinical Trials Browser

INDUSTRY × Expanded_access × Non Small Cell Lung Cancer ALK Positive or ROS1 Positive × Clear all

NCT03178071 2019-11-04

Expanded Access For Lorlatinib For Patients With Non Small Cell Lung Cancer ALK Positive or ROS1 Positive

No longer available

Non Small Cell Lung Cancer ALK Positive or ROS1 Positive